Bone Biologics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | |||
EBITDA | -809 | -903 | -769 | -2,080 |
EBIT | -1,807 | -1,929 | -4,161 | |
Net Income | -783 | -865 | -1,549 | -1,919 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -895 | -1,303 | -2,018 | -2,555 |
Cash | 2,332 | 3,227 | 3,026 | 4,452 |
Basic Shares | 1,168 | 660 | 534 | 391 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | 0 |
EBITDA | -9,428 | -4,396 | -803 | -825 |
EBIT | -18,856 | -3,665 | -1,101 | -825 |
Net Income | -8,948 | 695 | -1,610 | -1,824 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -24 | |||
Free Cash Flow | -9,555 | -3,566 | -1,228 | -426 |
Cash | 3,026 | 7,538 | 6,675 | 0 |
Basic Shares | 263 | 47 | 18 | 12 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.67 |
2024-03-31 | -$1.31 |
2023-12-31 | -$2.47 |
2023-09-30 | -$0.61 |
